The use of probiotics in gastrointestinal disease

Canadian Journal of Gastroenterology

Volumn 15, Issue 12, 2001, Pages 817-822

  Madsen, Karen L ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Bifidobacteria; Diarrhea; Inflammatory bowel disease; Lactobacillus species; Prebiotic; Probiotic

Indexed keywords

ANTIBIOTIC AGENT; FRUCTOSE OLIGOSACCHARIDE; GALACTOSE OLIGOSACCHARIDE; INULIN; LACTITOL; LACTULOSE; MUCIN; OLIGOSACCHARIDE; PROBIOTIC AGENT; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL COUNT; BACTERIAL GROWTH; BIFIDOBACTERIUM BIFIDUM; CLINICAL TRIAL; CLOSTRIDIUM DIFFICILE; COLON FLORA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROHN DISEASE; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; GASTROINTESTINAL DISEASE; HOST; HUMAN; ILEITIS; IMMUNOMODULATION; INTESTINE LYMPHATIC TISSUE; LACTOBACILLUS; PRIORITY JOURNAL; PROTEIN SECRETION; QUALITY CONTROL; SACCHAROMYCES BOULARDII; STREPTOCOCCUS THERMOPHILUS; ULCERATIVE COLITIS;

EID: 0035716980     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2001/690741     Document Type: Article

References (45)

1. Probiotics in man and animals
2. Dietary modulation of the human colonic microbiotia: Introducing the concept of prebiotics
3. Effects of soybean oligosaccharides on human faecal microflora
4. Pubic health issues arising from microbiological and labelling quality of foods and supplements containing probiotic microorganisms
5. Antimicrobial peptides as mediators of epithelial host defense
6. The indigenous gastrointestinal microflora
7. Persistence of colonization of human colonic mucosa by a probiotic strain, Lactobacillus rhamnosus GG, after oral consumption
8. Clostridium difficile-associated diarrhoea in uremic patients
9. Successful treatment of relapsing Clostridium difficile colitis with Lactobacillus GG
10. Clinical studies of probiotic agents
11. A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease
12. Efficacy of Lactobacillus GG as a dirrheal preventive in travellers
13. Prophylactic efficacy of lactobacilli on traveller's diarrhea
14. Lactobacilli to prevent traveller's diarrhea?
15. Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children
16. Prevention of beta-lactam-associated diarrhea by Saccharomyces boulardii compared with placebo
17. Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: A prospective study
18. Impact on the composition of the faecal flora by a new probiotic preparation: Preliminary data on maintenance treatment of patients with ulcerative colitis
19. Oral bacteriology as maintenance treatment in patients with chronic pouchitis: A double-blind, placebo-controlled trial
20. Treatment of refractory pouchitis with prebiotic and probiotic therapy
21. Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: A randomised trial
22. Probiotic therapy with E. coli for ulcerative colitis: Take the good with the bad
23. Saccharomyces boulardii in maintenance treatment of Chrohn's disease
24. Combination of antibiotic and probiotic treatment is efficacious in prophylaxis of post-operative recurrence of Crohn's disease: A randomized controlled study vs mesalamine
25. Probiotic spectra of lactic acid bacteria
26. Lactose maldigestion
27. Lactic acid bacteria in health and disease
28. Antibacterial activity of lactic acid bacteria isolated from vacuum-packed meats
29. Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression
30. Prokaryotic regulation of epithelial responses by inhibition of IkappaB-alpha ubiquitination
31. Oral administration of Lactobacillus GG induces an anti-inflammatory, Th-2 mediated systemic immune response towards intestinal organisms
32. Probiotics, mononuclear cells, and epithelial cells: An anti-inflammatory network
33. Promotion of IgA immune response in patients with Crohn's disease by oral bacteriotherapy with Lactobacillus GG
34. Elevated IL-10 levels in pouch-tissue after probiotic therapy
35. Differential induction of colitis and gastritis in HLA-B27 trasgenic rats selectivity colonized with Baacteroides vulgatus or Esherichia coli
36. Microbial factors in the pathogenesis of Crohn's disease, ulcerative colitis, and experimental intestinal inflammation
37. Probiotics in chronic pouchitis: Restoring luminal microbial balance
38. Two cases of endocarditis due to Lactobacillus species, antimicrobial susceptibility, review and discussion of therapy
39. Lactobacillus bacteremia, description of the clinical course in adult patients without endocarditis
40. Lactobacillus rhamnosus septicemia in patients with prolonged aplasia receiving ceftazidimevancomycin
41. Lactobacillemia in liver transplant patients
42. Lactobacillemia in three patients with AIDS
43. Lactobacillus species as opportunistic pathogens in immunocompromised patients
44. Fungemia due to Saccharomyces species in a patient treated with enteral Saccharomyces boulardii
45. Health benefits of probiotics